|
Delayed
Australian S.E.
22:11:47 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 0.0890 AUD | 0.00% |
|
-3.26% | -4.30% |
| 08-28 | Noxopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 05-25 | Noxopharm says new data confirms cancer-fighting potential | RE |
| Market Cap | 26.73M 19.13M 16.5M 15.52M 14.14M 26.59M 1.82B 183M 71.41M 923M 71.81M 70.25M 3.06B | P/E 2024 |
-5.39x | P/E 2025 | -3.23x |
|---|---|---|---|---|---|
| Enterprise Value | 27.65M 19.79M 17.07M 16.06M 14.63M 27.51M 1.88B 190M 73.88M 955M 74.29M 72.68M 3.17B | EV / Sales 2024 |
7.07x | EV / Sales 2025 | 5.92x |
| Free-Float |
71.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -3.26% | ||
| 1 month | +8.54% | ||
| 3 months | +3.49% | ||
| 6 months | +34.85% | ||
| Current year | -4.30% |
| 1 week | 0.08 | 0.09 | |
| 1 month | 0.08 | 0.1 | |
| Current year | 0.05 | 0.11 | |
| 1 year | 0.05 | 0.11 | |
| 3 years | 0.03 | 0.16 | |
| 5 years | 0.03 | 0.6 | |
| 10 years | 0.03 | 1.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Laczka
CEO | Chief Executive Officer | - | 2026-04-14 |
| Director of Finance/CFO | - | 2019-02-28 | |
Lara Babich
PRN | Corporate Officer/Principal | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
CHM | Chairman | 70 | 2016-03-14 |
Boris Patkin
BRD | Director/Board Member | - | 2020-03-25 |
Fred Bart Bart
CHM | Chairman | 71 | 2020-09-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/20/23 | Buy | Chairman | 880 | 0.0003% | ||
| 9/17/23 | Buy | Chairman | 253,001 | 0.0866% | ||
| 7/3/23 | Buy | Chairman | 135,281 | 0.0463% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -3.26% | -22.61% | +147.22% | 19.58M | ||
| +0.21% | -2.69% | +1.19% | +17.32% | 49.81B | ||
| +2.09% | -0.71% | +452.73% | +498.77% | 44.06B | ||
| -1.09% | -0.41% | +35.40% | +15.17% | 42.99B | ||
| -0.26% | -4.71% | +17.19% | +71.67% | 40.88B | ||
| -0.48% | -3.09% | +17.78% | +49.80% | 33.11B | ||
| -1.81% | -5.02% | +22.65% | +113.24% | 16.58B | ||
| -1.06% | +2.87% | - | - | 17.27B | ||
| -1.35% | -3.40% | +10.13% | +26.34% | 14.63B | ||
| -2.05% | -5.14% | +72.89% | +34.69% | 13.76B | ||
| Average | -0.74% | -1.80% | +67.48% | +108.25% | 27.31B | |
| Weighted average by Cap. | -0.51% | -1.79% | +95.16% | +120.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.4M 1.72M 1.48M 1.39M 1.27M 2.39M 163M 16.47M 6.41M 82.91M 6.45M 6.31M 275M | 2.82M 2.02M 1.74M 1.64M 1.49M 2.81M 192M 19.36M 7.54M 97.44M 7.58M 7.41M 323M |
| Net income | -3.58M -2.56M -2.21M -2.08M -1.89M -3.56M -243M -24.56M -9.56M -124M -9.61M -9.4M -410M | -4.88M -3.49M -3.01M -2.84M -2.58M -4.86M -332M -33.52M -13.05M -169M -13.12M -12.84M -559M |
| Net Debt | -2.32M -1.66M -1.43M -1.35M -1.23M -2.31M -158M -15.92M -6.2M -80.14M -6.23M -6.1M -266M | 925K 662K 571K 537K 489K 920K 62.81M 6.35M 2.47M 31.95M 2.48M 2.43M 106M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | A$0.0890 | 0.00% | 123,298 |
| 26-08-31 | A$0.0890 | +5.95% | 4,873 |
| 26-08-28 | A$0.0840 | -6.67% | 51,074 |
| 26-08-27 | A$0.0900 | -2.17% | 10,775 |
| 26-08-26 | A$0.0920 | -3.16% | 20,491 |
- Stock Market
- Stocks
- NOX Stock
Select your edition
All financial news and data tailored to specific country editions
















